Flow Cytometry Blood Test for Myeloma MRD Detection Launches
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Flow Cytometry |
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read MorePosted by CLP Edit Staff | Jan 20, 2026 | Cancer |
The collaboration will utilize Guardant’s liquid biopsy portfolio for the development of companion diagnostics for drug approvals.
Read MorePosted by CLP Edit Staff | Dec 1, 2025 | Molecular Diagnostics |
The proposed order would shift these test systems to Class II with special controls, replacing the current PMA requirement for companion diagnostics and related oncology assays.
Read MorePosted by CLP Edit Staff | Nov 14, 2025 | Molecular Diagnostics |
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read MorePosted by CLP Edit Staff | Sep 30, 2025 | Quality Control Programs |
Performance and Diagnostics Insights platform provides comparative analytics to help labs optimize operations and improve patient care.
Read More